BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Catalyst Brief//FDA catalyst calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Catalyst Brief — FDA catalyst calendar
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:event-15@catalystbrief.girapphe.com
DTSTAMP:20261117T061545Z
LAST-MODIFIED:20261117T061545Z
DTSTART;VALUE=DATE:20270301
DTEND;VALUE=DATE:20270302
SUMMARY:Readout: Beijing Suncadia Pharmaceuticals Co.\, Ltd — SHR-1918/ S
 HR-1918 placebo [Mar 2027]
DESCRIPTION:Phase 3 primary completion: A Study of SHR-1918 In Participants
  With Hypertriglyceridemia.\nSource: https://clinicaltrials.gov/study/NCT0
 7349615\nhttps://catalystbrief.girapphe.com/e/15?lang=en\nNot investment a
 dvice. Dates may change.
URL:https://catalystbrief.girapphe.com/e/15?lang=en
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
